Leap Therapeutics Inc (LPTX)
3.17
+0.04
(+1.28%)
USD |
NASDAQ |
May 03, 09:52
Leap Therapeutics 1 Year Total Returns (Daily): -21.75% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -21.75% |
May 01, 2024 | -18.25% |
April 30, 2024 | -20.78% |
April 29, 2024 | -21.54% |
April 26, 2024 | -10.44% |
April 25, 2024 | -11.94% |
April 24, 2024 | -6.85% |
April 23, 2024 | -13.11% |
April 22, 2024 | -12.84% |
April 19, 2024 | -25.73% |
April 18, 2024 | -23.06% |
April 17, 2024 | -18.92% |
April 16, 2024 | -24.15% |
April 15, 2024 | -23.64% |
April 12, 2024 | -8.22% |
April 11, 2024 | 3.83% |
April 10, 2024 | -3.49% |
April 09, 2024 | 10.00% |
April 08, 2024 | -16.77% |
April 05, 2024 | -23.03% |
April 04, 2024 | -19.03% |
April 03, 2024 | -22.42% |
April 02, 2024 | -22.65% |
April 01, 2024 | -19.12% |
March 28, 2024 | -14.19% |
Date | Value |
---|---|
March 27, 2024 | -4.17% |
March 26, 2024 | -21.99% |
March 25, 2024 | -24.50% |
March 22, 2024 | -24.78% |
March 21, 2024 | -24.24% |
March 20, 2024 | -27.14% |
March 19, 2024 | -39.59% |
March 18, 2024 | -41.24% |
March 15, 2024 | -46.49% |
March 14, 2024 | -50.00% |
March 13, 2024 | -51.80% |
March 12, 2024 | -46.81% |
March 11, 2024 | -47.23% |
March 08, 2024 | -49.93% |
March 07, 2024 | -55.09% |
March 06, 2024 | -56.45% |
March 05, 2024 | -54.14% |
March 04, 2024 | -52.55% |
March 01, 2024 | -51.07% |
February 29, 2024 | -51.06% |
February 28, 2024 | -50.01% |
February 27, 2024 | -45.49% |
February 26, 2024 | -46.67% |
February 23, 2024 | -51.31% |
February 22, 2024 | -50.32% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.63%
Minimum
Sep 07 2023
166.3%
Maximum
Dec 21 2020
-23.08%
Average
-27.13%
Median
Jun 13 2023
1 Year Total Returns (Daily) Benchmarks
Cutera Inc | -87.68% |
OrthoPediatrics Corp | -31.58% |
AIM ImmunoTech Inc | -16.66% |
Protalix BioTherapeutics Inc | -56.06% |
Armata Pharmaceuticals Inc | 65.23% |